Perspectives on dynamic optimisation and control theory in treating hyperlipidaemia.
Vernon
John A
JA
D003362:Cost-Benefit Analysis; D017850:Economics, Pharmaceutical; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics*; D006949:Hyperlipidemias / Q000188:drug therapy / Q000191:economics*
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors